EFIRUB Pastilles Colas
Food supplement declared in France, declaration No 2024-3-1264, decision dated 22 March 2024
EFIRUB Pastilles Colas is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- LES TROIS CHENES
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Pastille
- Daily dose
- 6
- Directions for use
- Prendre 1 à 6 pastilles par jour. A sucer.
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants en bas âge (1 à 3 ans), Femmes enceintes, Enfants (de moins de 6 ans)
- Objectives stated by the manufacturer (these are not authorised claims)
- Immunité
- Flavourings
- Cola
Declaration 303226, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Zingiber officinale Roscoe | Rhizome | Poudre (de plantes séchées ou broyées) | 252 mg |
| Salvia officinalis L. | Feuille | Extrait sec aqueux | 252 mg |
| Sisymbrium officinale (L) Scop. | Parties aériennes | Extrait sec aqueux | 168 mg |
| Althaea officinalis L. | Racine | Extrait sec aqueux | 126 mg |
| Citrus paradisi Macfad. | Pépin | Extrait sec hydroalcoolique | 50.4 mg |
Other active ingredients
Additives
E420, E967, E330, E470b, E504, E955
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Déconseillé en cas de traitement médicamenteux concomitant contenant de la guimauve (60 minutes d’intervalle).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Zingiber officinale Roscoe
Read the warning, when it applies and the studies cited
GINGER - ZINGIBER OFFICINALE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Salvia officinalis L.
Read the warning, when it applies and the studies cited
SAGE - SALVIA OFFICINALIS - Buccal
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
SAGE -SALVIA OFFICINALIS Oral
Cautions and warnings
Condition of application: Carminative, Diaphoretic, Antihidrotic, Antigalactagogue.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Condition of application: All products.
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have a seizure disorder such as epilepsy (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Althaea officinalis L.
Read the warning, when it applies and the studies cited
Marshmallow - ALTHAEA OFFICINALIS - Root
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Health Canada monograph dated 19 December 2025
MARSHMALLOW - ALTHAEA OFFICINALIS - LEAF
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.